US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

HARVARD BIOSCIENCE INC

us-stock
To Invest in {{usstockname}}
us-stock
$0.7125 0.0106(1.06%) HBIO at 04 Dec 2025 04:33 PM Medical Instruments & Supplies
Lowest Today 0.7002
Highest Today 0.737
Today’s Open 0.7012
Prev. Close 0.72
52 Week High 2.38
52 Week Low 0.28
Day’s Range: Low 0.7002 High 0.737
52-Week Range: Low 0.28 High 2.38
1 day return -
1 Week return -5.82
1 month return +17.04
3 month return +54.55
6 month return +80.88
1 year return -67.57
3 year return -74.17
5 year return -81.6
10 year return -

Institutional Holdings

AMH Equity Ltd 7.88

Harvey Partners LLC 4.81

Harvey Partners Small-Cap Opportunity 4.42

Vanguard Group Inc 4.16

Granahan Investment Management Inc.. 3.37

Vanguard Total Stock Mkt Idx Inv 2.77

Dimensional Fund Advisors, Inc. 2.53

BlackRock Inc 2.50

Meros Investment Management, LP 2.07

UBS Group AG 1.78

Renaissance Technologies Corp 1.78

Millennium Management LLC 1.44

Acuitas Investments, LLC 1.10

Geode Capital Management, LLC 0.99

Granahan SC Advantage 0.97

JNL Multi-Manager Small Cap Growth A 0.97

Vanguard Institutional Extnd Mkt Idx Tr 0.89

Pasadena Private Wealth, LLC 0.55

Granahan Inv Mgt Sm-Cap Core Gr 0.50

Victory Small Cap Stock 0.50

Fidelity Extended Market Index 0.49

Goldman Sachs Group Inc 0.47

Two Sigma Investments LLC 0.44

Northern Trust Corp 0.42

Acuitas US Microcap Institutional 0.41

RBF LLC 0.36

State Street Corp 0.34

Susquehanna International Group, LLP 0.32

DFA US Small Cap I 0.31

Marshall Wace Asset Management Ltd 0.31

Granahan Inv Mgt Small Cap Discoveries 0.26

DFA US Targeted Value I 0.23

Dimensional US Small Cap ETF 0.18

DFA US Core Equity 1 I 0.18

Dimensional US Targeted Value ETF 0.18

Dimensional US Core Equity 2 ETF 0.18

DFA US Core Equity 2 I 0.16

Fidelity Total Market Index 0.16

Extended Equity Market Fund K 0.15

Fidelity Series Total Market Index 0.12

Market Status

Strong Buy: 1

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 32.10 M

PB Ratio 2.4258

PE Ratio 0.0

Enterprise Value 70.09 M

Total Assets 126.64 M

Volume 688067

Company Financials

Annual Revenue FY23:112524000 112.5M, FY22:113335000 113.3M, FY21:118904000 118.9M, FY20:102100000 102.1M, FY19:116176000 116.2M

Annual Profit FY23:65579000 65.6M, FY22:60819000 60.8M, FY21:67652000 67.7M, FY20:58041000 58.0M, FY19:64322000 64.3M

Annual Net worth FY23:-3263000 -3.3M, FY22:-9516000 -9.5M, FY21:-288000 -0.3M, FY20:-7810000 -7.8M, FY19:-4687000 -4.7M

Quarterly Revenue Q3/2025:20591000 20.6M, Q2/2025:20450000 20.5M, Q1/2025:21774000 21.8M, Q3/2024:21970000 22.0M, Q2/2024:23097000 23.1M

Quarterly Profit Q3/2025:12021000 12.0M, Q2/2025:10371000 10.4M, Q1/2025:12184000 12.2M, Q3/2024:12765000 12.8M, Q2/2024:11887000 11.9M

Quarterly Net worth Q3/2025:-1231000 -1.2M, Q2/2025:-2282000 -2.3M, Q1/2025:-50340000 -50.3M, Q3/2024:-4802000 -4.8M, Q2/2024:-2927000 -2.9M

Fund house & investment objective

Company Information Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States, Germany, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Organisation Medical Instruments & Supplies

Employees 330

Industry Medical Instruments & Supplies

CEO Mr. John Duke

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right